Krishnan Krish S sold KRYS
July 10, 2025 · Form 4 insider transaction
Krishnan Krish S sold 6,500 shares of Krystal Biotech, Inc. at $150.23 per share, a transaction worth $976.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma M. Krishnan, that started on September 12, 2024 and will terminate on September 13, 2025.; The transaction was executed in multiple trades ranging from $150.00 to $150.8500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.; Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.